MJ,
Have you ever given any consideration as to what the SP might look like if the current CEO had not got shareholder approval to purchase Advangen and had not brought that along to be a commercially viable asset for Cellmid?
Have you also given any consideration to the fact that at least some of the Sophisticated Investors, Institutions and Dennis Eck may possibly have some inkling of what this is all about and said inkling being sufficient to warrant plonking down 9 million dosh in support?
If that is not a vote of confidence in the company, CEO, and Directors then do you have a plausible explanation?
CDY Price at posting:
38.5¢ Sentiment: Buy Disclosure: Held